Geographic variations in activity of broad-spectrum beta-lactams against Pseudomonas aeruginosa: summary of the worldwide SENTRY Antimicrobial Surveillance Program (1997-2000)
Clicks: 372
ID: 115565
2002
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Popular Article
30.0
/100
372 views
52 readers
AI Quality Assessment
Not analyzed
Readership in this journal
PopularRanked #11 of 48 articles by views in Diagnostic microbiology and infectious disease
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
With reports of increasing resistance to antimicrobial agents among Pseudomonas aeruginosa clinical isolates worldwide, the activities of cefepime and eight other broad-spectrum beta-lactams against 6969 isolates collected during 1997-2000 from the four regions of the SENTRY Antimicrobial Surveillan …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (37 words).
Try re-searching for a better abstract.
| Reference Key |
rn2002diagnosticgeographic
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Jones RN;Kirby JT;Beach ML;Biedenbach DJ;Pfaller MA;; |
| Journal | Diagnostic microbiology and infectious disease |
| Year | 2002 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
research support
non-u.s. gov't
population surveillance
pseudomonas aeruginosa / drug effects*
anti-bacterial agents / pharmacology
pseudomonas infections / microbiology
pseudomonas aeruginosa / isolation & purification
fluoroquinolones
global health
anti-infective agents / pharmacology
pmid:12106958
doi:10.1016/s0732-8893(02)00390-5
ronald n jones
jeffrey t kirby
michael a pfaller
aminoglycosides
cefepime
ceftazidime / pharmacology
cephalosporins / pharmacology
beta-lactams / pharmacology*
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.